Data / Drug companies / ProPharma Distribution
ProPharma Distribution: 102 products in the FDA NDC directory, labeler code 84549
ProPharma Distribution (labeler code 84549) lists 102 products in the FDA National Drug Code Directory, covering 65 finished drugs by generic name. By type: 102 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 3, 2024.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 84549
- Products in commercial distribution
- 102
- Packages
- 102
- Finished drugs by generic name
- 65
- Prescription products
- 102
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- April 27, 1955
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 74 | 72.5% |
| New drug applications (NDA) | 28 | 27.5% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 102 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 63 | 61.8% |
| Injection | 26 | 25.5% |
| Injection, powder, for solution | 5 | 4.9% |
| Injection, solution, concentrate | 2 | 2% |
| Emulsion | 2 | 2% |
| Tablet | 1 | 1% |
| Suspension | 1 | 1% |
| Injection, powder, lyophilized, for solution | 1 | 1% |
| Solution | 1 | 1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Rocuronium bromide | 84549-131 | Injection, solution | Generic drugs (ANDA) | October 3, 2024 |
| Dextrose | 84549-460 | Injection, solution | Generic drugs (ANDA) | July 9, 2024 |
| Atropine Sulfate | 84549-631 | Solution | Generic drugs (ANDA) | July 4, 2024 |
| Diltiazem Hydrochloride | 84549-319 | Injection, solution | Generic drugs (ANDA) | June 1, 2024 |
| Lidocaine Hydrochloride | 84549-005 | Injection, solution | Generic drugs (ANDA) | May 1, 2024 |
| Sodium bicarbonate | 84549-050 | Injection, solution | Generic drugs (ANDA) | March 15, 2024 |
| Rocuronium Bromide | 84549-687 | Injection | Generic drugs (ANDA) | October 15, 2023 |
| Rocuronium Bromide | 84549-141 | Injection, solution | Generic drugs (ANDA) | July 12, 2023 |
| Ketorolac tromethamine | 84549-119 | Injection, solution | Generic drugs (ANDA) | June 23, 2023 |
| Atropine Sulfate | 84549-400 | Injection, solution | Generic drugs (ANDA) | May 11, 2023 |
| Adenosine | 84549-318 | Injection | Generic drugs (ANDA) | March 15, 2023 |
| Furosemide | 84549-474 | Injection, solution | Generic drugs (ANDA) | February 1, 2023 |
| Furosemide | 84549-251 | Injection, solution | Generic drugs (ANDA) | February 1, 2023 |
| Epinephrine | 84549-018 | Injection | New drug applications (NDA) | January 30, 2023 |
| Ciprofloxacin in Dextrose | 84549-300 | Injection, solution | Generic drugs (ANDA) | December 1, 2022 |
| Phenylephrine hydrochloride | 84549-621 | Injection | Generic drugs (ANDA) | August 31, 2022 |
| Vasopressin | 84549-370 | Injection | Generic drugs (ANDA) | August 15, 2022 |
| Atropine Sulfate | 84549-001 | Injection, solution | Generic drugs (ANDA) | August 2, 2022 |
| Verapamil hydrochloride | 84549-605 | Injection, solution | Generic drugs (ANDA) | June 16, 2022 |
| Triamcinolone Acetonide | 84549-781 | Suspension | Generic drugs (ANDA) | May 2, 2022 |
| Ephedrine sulfate | 84549-611 | Injection | Generic drugs (ANDA) | April 15, 2022 |
| Revonto | 84549-003 | Injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 9, 2021 |
| Acetaminophen | 84549-100 | Injection | New drug applications (NDA) | February 18, 2021 |
| Atropine Sulfate | 84549-340 | Injection | Generic drugs (ANDA) | February 17, 2021 |
| Dexmedetomidine | 84549-230 | Injection, solution | Generic drugs (ANDA) | January 19, 2021 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.